Your browser doesn't support javascript.
loading
Association between COVID-19 morbidity and mortality rates and BCG vaccination policies in OECD countries.
Senoo, Yuki; Suzuki, Yosuke; Tsuda, Kenji; Tanimoto, Tetsuya; Takahashi, Kenzo.
Afiliación
  • Senoo Y; Medical Governance Research Institute, Minato-ward, Tokyo, Japan.
  • Suzuki Y; Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Tsuda K; Medical Governance Research Institute, Minato-ward, Tokyo, Japan.
  • Tanimoto T; Department of Obstetrics and Gynecology, Tone Chuo Hospital, Numata-shi, Gunma, Japan.
  • Takahashi K; Medical Governance Research Institute, Minato-ward, Tokyo, Japan.
J Infect Prev ; 22(2): 91-93, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33859726
ABSTRACT
We compared whether the national BCG vaccination (BCGV) policy influenced coronavirus disease 2019 (COVID-19) in Organisation for Economic Co-operation and Development (OECD) countries. Those currently implementing BCGV have a reduced number of COVID-19 morbidity and mortality cases, compared to those who have never implemented a BCGV policy, suggesting the potential protective effect of BCGV against COVID-19.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Infect Prev Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Infect Prev Año: 2021 Tipo del documento: Article País de afiliación: Japón